BMRN
#859
BioMarin Pharmaceutical Inc. - Common Stock
54.8 0 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.16%
Changement Mensuel
-17.59%
Evolution sur 6 mois
+0.68%
Changement Annuel
+4.68%
Clôture Précédente
54.8 9
Open
54.8 0
Low
54.4 8
High
55.9 8
Financials
- Market Capitalization 10.61 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
33.02
ratio cours/chiffre d'affaires
3.64
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 847 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 471.75 USD | -1.08% | -6.58% | -12.64% | +11.36% | 10.90 B USD | ||
| 857 |  PCVX Vaxcyte, Inc. - Common Stock | 71.38 USD | +9.78% | -18.15% | +18.89% | +68.75% | 10.62 B USD | ||
| 890 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.78 USD | +1.31% | +5.02% | +2.43% | +101.24% | 10.15 B USD | ||
| 907 |  KRYS Krystal Biotech, Inc. - Common Stock | 331.61 USD | +1.32% | +2.42% | -5.46% | +77.21% | 9.82 B USD |